This is a preview of subscription content, log in via an institution to check access.
Reference
Nicod E, et al. Are supplemental appraisal/reimbursement processes needed for rare disease treatments? An international comparison of country approaches Orphanet Journal of Rare Diseases 15: No. 189, 20 Jul 2020. Available from: URL: https://doi.org/10.1186/s13023-020-01462-0
Rights and permissions
About this article
Cite this article
Supplemental appraisal processes required for rare disease therapy?. PharmacoEcon Outcomes News 859, 32 (2020). https://doi.org/10.1007/s40274-020-7041-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7041-9